MA H2316 | 2021-2022 | 192nd General Court

Note: Legislation replaced by H5281

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on March 29 2021 - 25% progression, died in chamber
Action: 2022-09-22 - Accompanied a study order, see H5281
Text: Latest bill text (Introduced) [PDF]

Summary

Relative to prescriptions for testosterone therapy medications. Public Health.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Authorizing a 90-day supply of medically necessary testosterone therapy medication

Sponsors


History

DateChamberAction
2022-09-22HouseAccompanied a study order, see H5281
2022-07-07SenateSenate concurred
2022-06-27HouseReporting date extended to Sunday July 31, 2022, pending concurrence
2022-05-26HouseReported favorably by committee and referred to the Joint Committee on Health Care Financing
2022-02-17SenateSenate concurred
2022-02-17HouseReporting date extended to Saturday December 31, 2022, pending concurrence
2021-05-21JointHearing scheduled for 06/07/2021 from 10:00 AM-02:00 PM in Virtual Hearing
2021-03-29SenateSenate concurred
2021-03-29HouseReferred to the Joint Committee on Public Health

Same As/Similar To

S1953 (Similar To) 2023-01-03 - No further action taken
S530 (Similar To) 2022-03-07 - Bill reported favorably by committee and referred to the committee on Senate Ways and Means
S1991 (Similar To) 2022-10-03 - Accompanied a study order, see H5248
H5281 (Replaced by) 2023-01-03 - No further action taken

Massachusetts State Sources


Bill Comments

feedback